Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,534 | 418 | 95.9% |
| Education | $321.17 | 5 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,541 | 68 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $701.07 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $692.83 | 49 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $656.10 | 42 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $594.49 | 30 | $0 (2024) |
| GENZYME CORPORATION | $471.91 | 28 | $0 (2024) |
| Mylan Specialty L.P. | $446.86 | 33 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $376.77 | 22 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $345.76 | 13 | $0 (2024) |
| Grifols USA, LLC | $284.67 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,330 | 109 | AstraZeneca Pharmaceuticals LP ($510.45) |
| 2023 | $2,158 | 125 | AstraZeneca Pharmaceuticals LP ($318.00) |
| 2022 | $1,802 | 95 | AstraZeneca Pharmaceuticals LP ($478.81) |
| 2021 | $1,565 | 94 | AstraZeneca Pharmaceuticals LP ($233.83) |
All Payment Transactions
423 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Immunology | ||||||
| 11/26/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Genentech USA, Inc. | Xolair | Food and Beverage | In-kind items and services | $17.18 | General |
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.39 | General |
| 11/06/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardio-pulmonary | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $38.22 | General |
| Category: NEUROLOGY | ||||||
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 578 | 741 | $160,130 | $48,729 |
| 2022 | 3 | 478 | 679 | $147,260 | $49,964 |
| 2021 | 5 | 487 | 729 | $165,779 | $56,979 |
| 2020 | 9 | 501 | 727 | $157,700 | $46,753 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 367 | 495 | $126,240 | $37,487 | 29.7% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 111 | 130 | $13,000 | $4,861 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 40 | $13,120 | $4,500 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,070 | $1,178 | 23.2% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 41 | 42 | $2,100 | $596.93 | 28.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 20 | 20 | $600.00 | $105.80 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 370 | 544 | $125,120 | $41,308 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 48 | $13,440 | $5,300 | 39.4% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2022 | 76 | 87 | $8,700 | $3,356 | 38.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 400 | 626 | $143,980 | $49,059 | 34.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 48 | $13,440 | $5,467 | 40.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $5,355 | $1,356 | 25.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 15 | $2,130 | $774.54 | 36.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 22 | 23 | $874.00 | $322.30 | 36.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 382 | 606 | $139,280 | $39,499 | 28.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 19 | 20 | $5,600 | $1,896 | 33.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $5,985 | $1,736 | 29.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,045 | $778.14 | 74.5% |
| 94660 | Initiation and management of continued pressured respiratory assistance by mask or breathing tube | Office | 2020 | 18 | 18 | $1,800 | $753.24 | 41.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 12 | 12 | $720.00 | $720.00 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 13 | $1,846 | $587.36 | 31.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $880.00 | $513.53 | 58.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 17 | $544.00 | $269.79 | 49.6% |
About Nicole Bowman, N.P
Nicole Bowman, N.P is a Family healthcare provider based in Shelbyville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2013. The National Provider Identifier (NPI) number assigned to this provider is 1225474695.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nicole Bowman, N.P has received a total of $7,855 in payments from pharmaceutical and medical device companies, with $2,330 received in 2024. These payments were reported across 423 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,534).
As a Medicare-enrolled provider, Bowman has provided services to 2,044 Medicare beneficiaries, totaling 2,876 services with total Medicare billing of $202,425. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Shelbyville, IN
- Active Since 05/13/2013
- Last Updated 08/30/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1225474695
Products in Payments
- DUPIXENT (Biological) $1,272
- GLASSIA (Biological) $656.10
- TEZSPIRE (Biological) $632.71
- FASENRA (Biological) $446.98
- NUCALA (Biological) $382.94
- OFEV (Drug) $313.65
- XYWAV (Drug) $298.75
- Prolastin-C Liquid (Biological) $284.67
- STIOLTO RESPIMAT (Drug) $280.84
- YUPELRI (Drug) $276.16
- TRELEGY ELLIPTA (Drug) $260.37
- Wakix (Drug) $244.99
- ACTHAR (Biological) $214.96
- TYVASO (Drug) $180.57
- Yupelri (Drug) $170.70
- Arikayce (Drug) $144.08
- WAKIX (Drug) $131.78
- Sunosi (Drug) $131.06
- BREZTRI (Drug) $85.68
- SMARTVEST (Device) $81.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Shelbyville
Melanie Dowell, Fnp, FNP
Family — Payments: $5,128
Dr. Kenda Harrison, Np, NP
Family — Payments: $4,108
Kathryn Neisler, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $4,073
Mrs. Kristin Mcbay, Np-C, NP-C
Family — Payments: $3,482
Arise Uwizeyimana
Family — Payments: $3,423
Suzanna Carlton, Fnp, FNP
Family — Payments: $3,210